Serum TSH levels are high in most cases of
Rationale:
High serum TSH levels are typical in most cases of myxoedema. This condition results from a deficiency of thyroid hormones, leading to elevated TSH as the body attempts to stimulate hormone production.
B: Grave's disease High serum TSH levels do not characterize Grave's disease, as this hyperthyroid condition commonly results in suppressed TSH due to elevated thyroid hormone levels.
C: Carcinoma thyroid Generally, thyroid carcinoma is associated with normal or low TSH levels, as the malignancy does not typically influence the feedback mechanism regulating TSH production.
D: Toxic nodular goiter In toxic nodular goiter, excessive thyroid hormone production suppresses TSH levels, making high serum TSH levels unlikely in this hyperthyroid state.
The principle source of circulating estrogen in menstruating women is
Rationale:
Granulosa cells are the principal source of circulating estrogen in menstruating women. These cells, located in the ovarian follicles, produce estrogen in response to follicle-stimulating hormone, playing a crucial role in the menstrual cycle and fertility.
B: Breast cells produce milk and are not involved in estrogen production during the menstrual cycle, making them unrelated to circulating estrogen levels in menstruating women.
C: Placenta primarily produces hormones during pregnancy, not in menstruating women, thus limiting its role in circulating estrogen levels outside of gestation.
D: Gonadotropes release hormones that stimulate the ovaries but do not directly produce estrogen themselves, which is specifically synthesized by granulosa cells within the ovarian follicles.
In the treatment of hypothyroidism, thyroxine is preferred over liothyronine because thyroxine
Rationale:
Thyroxine has a longer half-life. This property allows for more stable and sustained levels of thyroid hormone in the body, making it more effective for long-term management of hypothyroidism compared to liothyronine.
A: Can be made more easily by recombinant DNA technology. While recombinant DNA technology is useful, it does not specifically determine the efficacy or suitability of thyroxine over liothyronine in treatment.
C: Has higher affinity for thyroid hormone receptors. The affinity for receptors does not solely dictate the effectiveness of thyroid hormone replacement therapy in managing hypothyroidism, making this option misleading.
D: Is faster acting. Faster action is not a desired characteristic for long-term treatment of hypothyroidism, as a gradual and steady release is preferred for maintaining hormone balance.
Folinic acid is principally used
Rationale:
Folinic acid is principally used along with methotrexate therapy. This option is accurate because folinic acid acts as a rescue agent to mitigate the toxic effects of methotrexate, enhancing treatment efficacy and reducing side effects in cancer therapy.
A: In pernicious anaemia. This condition primarily requires Vitamin B12 supplementation, as it is caused by the inability to absorb this vitamin, not by a deficiency in folinic acid.
B: In megaloblastic anaemia secondary to Vitamin $B_{12}$. While folinic acid may help, the treatment focuses on addressing Vitamin B12 deficiency to resolve the underlying cause of this anaemia.
D: In treatment of folic acid deficiency. Although folinic acid can aid in folate metabolism, it is not the first-line treatment for folic acid deficiency, which typically involves direct folic acid supplementation.
A 54-year-old obese patient with type 2 diabetes and a history of alcoholism probably should not receive metformin because it can increase his risk of
Rationale:
Lactic acidosis. Metformin can accumulate in patients with compromised renal function, especially in those with a history of alcoholism, increasing the risk of lactic acidosis, a potentially life-threatening condition.
A: A disulfiram-like reaction. This reaction is associated with alcohol consumption and certain medications like disulfiram, not metformin, making it irrelevant for this patient's treatment considerations.
B: Excessive weight gain. Metformin is often associated with weight loss or neutral effects rather than weight gain, contradicting the idea that it contributes to excessive weight increases in patients.
C: Hypoglycemia. Metformin typically does not cause hypoglycemia on its own; this risk is more commonly associated with other diabetes medications, thus making this option less applicable to metformin usage.
Progesterone administration
Rationale:
Progesterone administration sensitizes the uterus to oxytocin. This increased sensitivity is crucial for effective uterine contractions during labor, facilitating the birthing process and ensuring that oxytocin can exert its full influence when needed.
A: Suppresses onset of menstruation. While progesterone contributes to the menstrual cycle regulation, it does not primarily suppress menstruation but supports the maintenance of the uterine lining.
B: Induces watery cervical secretion. Progesterone primarily thickens cervical mucus, enhancing its barrier function rather than inducing a watery secretion that facilitates sperm passage.
D: Cornifies vaginal epithelium. This process is more closely associated with estrogen's influence; progesterone does not significantly contribute to the cornification of vaginal epithelial cells in the menstrual cycle.
The gut controls the entry of ingested iron in the body of
Rationale:
C: Complexing excess iron to form ferritin which remains stored in the mucosal cell and is shed off. The gut manages iron absorption by converting surplus iron into ferritin, effectively sequestering it in mucosal cells to prevent toxicity and regulate iron levels in the body.
A: Regulating the availability of apoferritin which acts as the carrier of iron across the mucosal cell. This option misrepresents the primary role of the gut, which focuses on storing excess iron rather than merely transporting it.
B: Regulating the turnover of apoferritin-ferritin interconversion in the mucosal cell. While relevant to iron metabolism, this choice does not accurately capture how the gut primarily manages excess iron.
D: Regulating the number of transferring receptors on the mucosal cell. This option emphasizes iron uptake rather than the gut's mechanism for handling excess iron through storage, which is central to iron homeostasis.
The purpose/purposes served by the progestin component of the combined estrogen + progestin contraceptive pill is/are
Rationale:
All of the above. The progestin component of combined contraceptive pills serves multiple purposes, including suppression of ovulation, reduction of endometrial cancer risk, and inducing a controlled withdrawal bleed at the cycle's end. This multifaceted approach enhances contraceptive efficacy and supports reproductive health.
A: Suppression of ovulation. While this is a significant function of progestin, it does not encompass all the roles it plays in contraceptive efficacy.
B: Prompt bleeding at the end of the course. This is merely one effect of progestin and overlooks its critical role in preventing endometrial cancer and suppressing ovulation.
C: Blockade of increased risk of endometrial carcinoma. This important benefit alone does not capture the entire spectrum of progestin's functions, such as ovulation suppression and menstrual regulation.
Which of the following changes in the patient's blood cell concentration most likely occurred as a result of her therapy?
Rationale:
Decreased lymphocytes. This change indicates a reduction in immune response, often a consequence of therapy that targets rapidly dividing cells, such as chemotherapy, which can affect lymphocyte production in the bone marrow.
A: Decreased neutrophils. While neutrophils may also decrease during certain therapies, the context specifically highlights lymphocytes as the primary affected cell type, making this option less relevant.
B: Decreased erythrocytes. Erythrocytes relate to oxygen transport and are not typically the primary target of therapies focused on immune modulation, thereby making this choice less likely in the given context.
C: Increased basophils. Basophils are rarely elevated in response to standard therapies; their increase usually indicates allergic reactions or parasitic infections, which do not align with the anticipated effects of the therapy discussed.
Which of the following drugs did the patient most likely take?
Rationale:
Leuprolide. This drug is a gonadotropin-releasing hormone (GnRH) agonist commonly used to treat hormone-sensitive conditions, making it a likely choice in the context provided, which emphasizes hormonal regulation.
A: Degarelix. This medication is a GnRH antagonist primarily used for prostate cancer, differing in mechanism and application from leuprolide, thus making it less likely in this scenario.
C: Cabergoline. Typically utilized to treat hyperprolactinemia, cabergoline functions differently compared to leuprolide and does not align with the context suggesting hormonal modulation for other conditions.
D: Pegvisomant. This drug is a growth hormone receptor antagonist, primarily indicated for acromegaly, and does not relate to the hormonal pathways that leuprolide targets, rendering it an unsuitable choice.
Therapeutically vitamin B1 has been employed most successfully in the treatment of
Rationale:
Vitamin B1 has been employed most successfully in the treatment of Beriberi.
Vitamin B1, also known as thiamine, is essential for energy metabolism, and its deficiency leads to Beriberi, characterized by neurological and cardiovascular symptoms. This vitamin's therapeutic use in Beriberi effectively addresses the root cause of the disease, restoring proper function and alleviating symptoms related to thiamine deficiency.
A: Microcytic anemia This condition primarily results from iron deficiency or other factors, not directly linked to vitamin B1 levels. Thus, thiamine does not treat microcytic anemia effectively.
B: Pellagra Pellagra arises from niacin deficiency, not thiamine. The symptoms of this condition, including dermatitis and diarrhea, require niacin supplementation for resolution, making thiamine ineffective.
C: Scurvy Scurvy is caused by a deficiency of vitamin C rather than vitamin B1. Therefore, the treatment of scurvy necessitates vitamin C, rendering thiamine irrelevant in this context.
A 63-year-old female presents to clinic for a diabetes follow-up. She has been taking metformin for 3 years now, but her blood sugars have not been well controlled over the past year. Her average morning fasting blood sugar is 165mg\dL, and her 2-h postprandial is 205mg\dL. Glimepiride is added to her regimen. What is the mechanism of action of glimepiride?
Rationale:
Glimepiride increases insulin release from the pancreatic beta cells, which helps lower blood sugar levels in patients with type 2 diabetes, making it effective in managing her hyperglycemia.
A: Decreased glucagon release Glimepiride does not primarily target glucagon secretion; its main action focuses on stimulating insulin production, not inhibiting glucagon.
C: Increased insulin sensitivity in peripheral tissues This medication does not directly enhance insulin sensitivity; its primary role is to boost insulin secretion rather than improve tissue responsiveness to insulin.
D: Inhibits hepatic gluconeogenesis Glimepiride does not inhibit glucose production in the liver; its mechanism centers around promoting insulin secretion rather than affecting gluconeogenesis directly.
Five patients with elevated cholesterol present to the ambulatory care clinic for treatment of abnormalities of cholesterol. Which of the following patients would best benefit from treatment with an HMG-CoA reductase inhibitor?
Rationale:
D: Total cholesterol = 220mg/dL, HDL = 100mg/dL. This patient has the highest total cholesterol level among the options, indicating a greater need for intervention with an HMG-CoA reductase inhibitor to effectively lower cholesterol levels and reduce cardiovascular risk.
A: Total cholesterol = 180mg/dL, HDL = 100mg/dL. Although HDL is high, the total cholesterol level is not sufficiently elevated to warrant treatment with an HMG-CoA reductase inhibitor.
B: Total cholesterol = 180mg/dL, LDL = 100mg/dL. This patient’s cholesterol levels are within a normal range, making HMG-CoA reductase inhibitor treatment unnecessary for managing their cholesterol abnormalities.
C: Total cholesterol = 180mg/dL, HDL = 60mg/dL. Despite an average HDL level, the total cholesterol remains low, suggesting that treatment with an HMG-CoA reductase inhibitor is not indicated at this point.
A 27-year-old woman with amenorrhea, infertility, and galactorrhea was treated with a drug that successful restored ovulation and menstruation. Before being given the drug, the woman was carefully questioned about previous mental health problems, which she did not have. She was advised to take the drug orally. The drug used to treat this patient was probably.
Rationale:
Bromocriptine. This medication is effective in treating conditions like amenorrhea and galactorrhea by reducing prolactin levels, thus restoring ovulation and menstruation, which aligns with the woman's symptoms and treatment outcome.
B: Desmopressin. This medication primarily treats diabetes insipidus and does not address hyperprolactinemia or related reproductive issues, making it unsuitable for restoring menstrual function in this patient.
C: Human gonadotropin hormone. While this hormone can stimulate ovulation, it does not directly target prolactin levels or address galactorrhea, which are central to the woman's condition.
D: Leuprolide. This medication is a GnRH agonist used to suppress gonadotropin release and is inappropriate for treating amenorrhea caused by elevated prolactin, which was the issue here.
The side effect which primarily limits acceptability of oral iron therapy is
Rationale:
Epigastric pain and bowel upset primarily limit the acceptability of oral iron therapy. These side effects can lead to discomfort and non-compliance among patients, making it challenging for them to continue the treatment effectively.
B: Black stools may occur with iron supplementation, but they are often perceived as benign and do not significantly impact a patient's willingness to continue therapy.
C: Staining of teeth is a concern with liquid iron preparations, yet this side effect is less prevalent compared to gastrointestinal discomfort and does not deter most patients.
D: Metallic taste can be bothersome but is generally not as debilitating as epigastric pain and bowel upset, thus having less influence on a patient's acceptance of oral iron therapy.
Which of the following would be an appropriate change in the treatment plan for a patient with osteoporosis and hypertension experiencing a significant decrease in bone mass despite current therapy?
Rationale:
C: Adding calcitonin to the current regimen is appropriate as it can help increase bone density and reduce the risk of fractures in patients with osteoporosis, especially when current therapies are inadequate.
A: Substitute hydrochlorothiazide with propranolol. This change does not address bone mass issues, as propranolol primarily manages hypertension and does not have a direct beneficial effect on bone density.
B: Substitute raloxifene with ethinyl estradiol. Changing to ethinyl estradiol may not effectively enhance bone mass since raloxifene is specifically indicated for osteoporosis management and provides protective effects on bone.
D: Increase the daily dose of calcium carbonate. Merely increasing calcium intake may not be sufficient to combat significant bone mass loss, as osteoporosis often requires more comprehensive treatment strategies beyond dietary adjustments.
All of the following conditions are causes of hyperthyroidism except
Rationale:
Hyperthyroidism is not caused by Hashimoto's thyroiditis. This autoimmune disorder typically leads to hypothyroidism, characterized by reduced thyroid hormone production, contrasting with the excessive hormone levels seen in hyperthyroidism.
A: Graves' disease This condition is the most common cause of hyperthyroidism, resulting from an autoimmune attack that stimulates excess hormone production by the thyroid gland.
C: Toxic multinodular goiter This condition involves multiple nodules in the thyroid that produce excessive hormones, thereby directly causing hyperthyroidism through increased hormone secretion.
D: Triiodothyronine toxicosis This condition refers to elevated levels of triiodothyronine, a thyroid hormone, leading to hyperthyroidism symptoms, as it indicates excess hormone activity in the body.
Glucose entry into the cells of the following organ/tissue is highly dependent on the presence of insulin.
Rationale:
Glucose entry into the cells of adipose tissue is highly dependent on the presence of insulin.
Insulin facilitates glucose uptake in adipose tissue by promoting the translocation of glucose transporter proteins to the cell surface, thereby enhancing glucose absorption. This mechanism is crucial for energy storage and regulation of blood sugar levels, highlighting the significant role of insulin in adipose tissue metabolism.
A: Brain Glucose entry in the brain primarily occurs via transporters that are not significantly influenced by insulin, allowing for a constant supply necessary for neuronal function.
B: Liver The liver can uptake glucose independently of insulin, particularly during periods of fasting or high glucose availability, utilizing different pathways for glucose regulation and storage.
D: Kidney tubules Glucose reabsorption in kidney tubules primarily relies on sodium-glucose transporters, functioning independently of insulin, thus maintaining glucose homeostasis regardless of hormonal influence.
The following may help alleviate symptoms associated with prostatic hyperplasia EXCEPT:
Rationale:
Clonidine may help alleviate symptoms associated with prostatic hyperplasia EXCEPT. This option is designed primarily as an antihypertensive and does not target the urinary symptoms associated with prostatic hyperplasia, unlike medications specifically aimed at this condition.
B: Tamsulosin primarily relaxes smooth muscles in the prostate and bladder neck, effectively improving urinary flow and alleviating symptoms of prostatic hyperplasia.
C: Doxazosin is an alpha-blocker that helps reduce urinary obstruction by relaxing muscle fibers in the prostate, making it beneficial for managing prostatic hyperplasia symptoms.
D: Finasteride works by inhibiting the conversion of testosterone to dihydrotestosterone, leading to a reduction in prostate size and an improvement in urinary symptoms associated with prostatic hyperplasia.
Which of the following actions was most likely to contribute to the therapeutic effect of prednisone in the patient's Crohn disease?
Rationale:
Increased catabolism of prostaglandins. Prednisone reduces inflammation in Crohn's disease by promoting the breakdown of prostaglandins, which are mediators of inflammation. This action helps alleviate symptoms and promotes healing in the gastrointestinal tract.
B: Decreased number of circulating neutrophils. While prednisone can affect neutrophil levels, this action mainly reduces immune response rather than directly contributing to the therapeutic effects on Crohn's disease.
C: Increased proliferation of T cells. Prednisone typically suppresses T cell activity rather than increasing their proliferation, which would not align with its therapeutic role in managing inflammation in Crohn's disease.
D: Increased activation of complement system. Activation of the complement system usually enhances inflammation and immune reactions, counteracting the intended anti-inflammatory effects of prednisone in treating Crohn's disease.
Which of the following was most likely the primary goal for restarting prednisone treatment in this patient?
Rationale:
To avoid opportunistic infections after surgery. Restarting prednisone treatment is crucial for patients with suppressed immune systems, as it helps maintain immune function and reduces the risk of infections during the postoperative period.
A: To avoid adrenal insufficiency after surgery. While adrenal insufficiency is a concern, the primary focus in this scenario is preventing infections rather than managing adrenal function post-surgery.
B: To speed up surgical wound healing. Prednisone does not enhance wound healing; in fact, it can impede the healing process by suppressing the inflammatory response necessary for recovery.
D: To promote gallbladder relaxation before surgery. Gallbladder relaxation is unrelated to prednisone treatment; this medication primarily influences immune response rather than affecting the gallbladder or its function.
In isolated fibroblast or epithelial cells, retinoids enhance the synthesis of following protein
Rationale:
Retinoids enhance the synthesis of fibronectin in isolated fibroblast or epithelial cells. This protein plays a crucial role in cell adhesion and extracellular matrix organization, which are vital for tissue repair and regeneration, demonstrating the significant influence of retinoids on cellular activities.
B: Collagenase This enzyme primarily breaks down collagen rather than being synthesized in response to retinoids, highlighting a misalignment with the context of protein synthesis enhancement.
C: Certain species of keratin While keratin is essential for cellular structure, retinoids specifically stimulate fibronectin synthesis rather than keratin production in isolated fibroblast or epithelial cells.
D: All of the above This option incorrectly suggests that retinoids promote the synthesis of multiple proteins, whereas evidence specifically supports only the enhancement of fibronectin synthesis.
Hormones that are useful in the diagnosis of endocrine insufficiency include
Rationale:
All of the above. Hormones like corticotropin-releasing hormone, cosyntropin, and gonadotropin-releasing hormone play crucial roles in diagnosing various forms of endocrine insufficiency by stimulating specific hormone release and assessing gland functionality.
A: Corticotropin-releasing hormone Stimulates adrenocorticotropic hormone release; however, it is just one aspect of evaluating endocrine function and does not encompass the full diagnostic spectrum.
B: Cosyntropin Primarily assesses adrenal function via stimulation of cortisol production, but it doesn't provide a comprehensive evaluation of all endocrine insufficiencies.
C: Gonadotropin-releasing hormone Primarily involved in reproductive health, it does not address other endocrine glands or their insufficiencies, limiting its diagnostic utility in broader contexts.
What is the antidote for Warfarin?
Rationale:
Vitamin K. This vitamin plays a crucial role in the coagulation process, counteracting the effects of Warfarin, an anticoagulant. Administering Vitamin K effectively restores the blood's ability to clot, making it the preferred antidote.
A: Vitamin D. This vitamin primarily supports bone health and calcium absorption, having no direct influence on blood clotting or the effects of anticoagulants like Warfarin.
B: Vitamin C. Known for its antioxidant properties, Vitamin C aids in immune function and skin health but does not interact with Warfarin's anticoagulant properties or serve as an antidote.
D: Vitamin B. While important for energy metabolism and neurological functions, Vitamin B does not play a role in blood coagulation and does not neutralize Warfarin's effects.
A diagram of the menstrual cycle in a 19-year-old woman who complains of dysmenorrhea is shown as follows. Which of the following points represents the highest level of estradiol?
Rationale:
C: The highest level of estradiol occurs around the time of ovulation, typically represented by point C in the menstrual cycle diagram. This peak is crucial for triggering ovulation and promoting reproductive health.
A: Letter A depicts the early follicular phase when estradiol levels are relatively low, as the follicles are still developing and have not yet reached peak hormone production.
B: Letter B represents the late follicular phase, where estradiol levels begin to rise but have not yet peaked, indicating that ovulation has not occurred at this point.
D: Letter D occurs in the luteal phase when estradiol levels start to decline after ovulation, indicating that the peak has already passed and hormonal levels are stabilizing.
A 45-year-old woman with diabetes and hypertension presents to the primary care clinic with a cough. The nonproductive cough started about 2 weeks ago. She has not had a fever, congestion, or been around any sick contacts. However, she was recently started on lisinopril. The physician decides to switch her to losartan, and the patient reports that her cough has ceased. What is the mechanism of action of losartan?
Rationale:
Losartan inhibits the angiotensin II receptor. This action blocks the effects of angiotensin II, a potent vasoconstrictor, leading to vasodilation, reduced blood pressure, and alleviation of conditions like cough associated with ACE inhibitors.
A: Activates angiotensin I receptor. Losartan does not activate this receptor; instead, it specifically targets angiotensin II receptors to exert its therapeutic effects on blood pressure.
B: Activates angiotensin II receptor. By activating this receptor, it would enhance the effects of angiotensin II, contradicting losartan's purpose of reducing its action and alleviating symptoms like cough.
C: Inhibits angiotensin-converting enzyme. This describes the action of ACE inhibitors, not losartan, which functions differently by blocking angiotensin II receptors rather than inhibiting the enzyme responsible for angiotensin II formation.
Hypercoagulability and dermal vascular necrosis due to protein C deficiency is known to be an early-appearing adverse effect of treatment with
Rationale:
Hypercoagulability and dermal vascular necrosis due to protein C deficiency is known to be an early-appearing adverse effect of treatment with Warfarin. Warfarin inhibits vitamin K-dependent coagulation factors, which can lead to a paradoxical increase in clotting, especially in patients with protein C deficiency, resulting in complications like vascular necrosis as a manifestation of this imbalance.
A: Aspirin inhibits platelet aggregation, primarily reducing thrombus formation, and does not typically induce hypercoagulability or vascular necrosis as seen with Warfarin treatment.
B: Clopidogrel, like Aspirin, functions as an antiplatelet agent and does not cause hypercoagulability or the specific vascular complications associated with protein C deficiency.
C: Heparin acts as an anticoagulant by enhancing antithrombin activity, effectively preventing clot formation and does not induce the adverse effects linked to protein C deficiency seen with Warfarin.
A 78-year-old postmenopausal woman has been steadily losing weight over the past 6 months. She has no family history of breast or endometrial cancer. Which steroid hormone could she be given to increase her appetite?
Rationale:
D: Megestrol can increase appetite and promote weight gain, making it particularly effective for patients experiencing anorexia or unintended weight loss, such as the 78-year-old postmenopausal woman in this scenario.
A: Drospirenone does not primarily serve to enhance appetite; instead, it is mainly used for hormonal contraceptive purposes and managing conditions like acne and premenstrual dysphoric disorder.
B: Ethinyl estradiol primarily functions as an estrogen in contraceptives and hormone replacement therapy, lacking specific appetite-stimulating properties that would address weight loss in this patient.
C: Medroxyprogesterone is utilized for various indications, including contraception and treating abnormal uterine bleeding, but it is not recognized for effectively stimulating appetite in individuals experiencing weight loss.
Carbimazole acts by inhibiting
Rationale:
Carbimazole acts by inhibiting the oxidation of iodide. This drug specifically targets the enzyme thyroid peroxidase, which is essential for the conversion of iodide to iodine, ultimately reducing thyroid hormone production.
A: Iodide trapping involves the uptake of iodide into the thyroid gland, a process not directly impacted by carbimazole, which focuses on the subsequent oxidation step.
C: Proteolysis of thyroglobulin refers to the breakdown of stored thyroid hormones, an action that occurs after hormone synthesis and is not affected by carbimazole’s mechanism of action.
D: Synthesis of thyroglobulin protein entails the creation of a precursor to thyroid hormones, which carbimazole does not inhibit, as its primary action is on iodide oxidation rather than protein synthesis.
A 56-year-old woman with diabetes who takes metformin is scheduled to undergo a CT scan of the abdomen and pelvis with IV contrast. Her last dose of metformin was this morning. She presents to the imaging center ready for the test. When she tells the technician that she takes metformin, her CT scan is cancelled despite her serum creatinine being 1mg\dL. What is the reason for cancellation of the test?
Rationale:
The reason for cancellation of the test is lactic acidosis development.
Metformin can accumulate in the body during procedures involving IV contrast, particularly if renal function is compromised. Lactic acidosis is a serious complication that can arise from this accumulation, especially in patients with diabetes, prompting the cancellation to ensure patient safety during imaging procedures.
A: Allergic reaction potential Contrast agents can cause allergic reactions, but the patient's renal function and metformin use are more critical in this scenario, making this option less relevant.
C: Nephrotoxic effects of the contrast While contrast can have nephrotoxic effects, the patient's serum creatinine level is normal, indicating her kidneys are functioning adequately at this time.
D: Neurotoxic effects of the contrast Neurotoxic effects from contrast agents are not a common concern in this context, as they primarily relate to other conditions or specific patient vulnerabilities not mentioned here.
Serum TSH levels are high in most cases of
Rationale:
High serum TSH levels are prevalent in most cases of Myxoedema. This condition typically arises from hypothyroidism, leading to elevated TSH as the body attempts to stimulate thyroid hormone production.
B: Grave's disease exhibits low TSH levels due to excessive thyroid hormone production, resulting from an autoimmune response that stimulates the thyroid gland, opposing the TSH elevation seen in Myxoedema.
C: Carcinoma thyroid can present with variable TSH levels, often depending on tumor characteristics and thyroid hormone secretion; high TSH is not a defining feature, unlike in Myxoedema.
D: Toxic nodular goiter generally leads to reduced TSH levels as nodules produce excess thyroid hormones, creating a feedback mechanism that suppresses TSH production, contrasting with the high levels seen in Myxoedema.
The principle source of circulating estrogen in menstruating women is
Rationale:
Granulosa cells are the principal source of circulating estrogen in menstruating women. These cells, located in the ovarian follicles, produce estrogen in response to follicle-stimulating hormone, playing a crucial role in the menstrual cycle and reproductive health.
B: Breast cells do not primarily produce estrogen; their function revolves around lactation and hormonal responses post-pregnancy, not the menstrual cycle.
C: Placenta is significant for estrogen production during pregnancy, but menstruating women primarily rely on ovarian sources like granulosa cells for their estrogen levels.
D: Gonadotropes produce luteinizing hormone and follicle-stimulating hormone, which regulate ovarian function but do not directly synthesize estrogen themselves.
In the treatment of hypothyroidism, thyroxine is preferred over liothyronine because thyroxine
Rationale:
Thyroxine has a longer half-life. This extended duration of action allows for more stable hormone levels in the body, making it a more effective and convenient choice for managing hypothyroidism compared to liothyronine, which requires more frequent dosing.
A: Can be made more easily by recombinant DNA technology. While recombinant DNA technology is significant, the preference for thyroxine is primarily due to its pharmacokinetic properties rather than its production method.
C: Has higher affinity for thyroid hormone receptors. Although receptor affinity is important, the longer half-life of thyroxine provides a more consistent therapeutic effect over time, making it preferable in treatment.
D: Is faster acting. Speed of action is not a primary factor in the treatment of hypothyroidism; the sustained release and stability of thyroxine over time are more critically valued in managing the condition.
Folinic acid is principally used
Rationale:
Folinic acid is principally used along with methotrexate therapy. This option is correct as folinic acid is specifically employed to mitigate the toxic effects of methotrexate, enhancing patient safety and treatment effectiveness in certain cancers and autoimmune diseases.
A: In pernicious anaemia This option is misleading since pernicious anaemia primarily involves Vitamin B12 deficiency rather than necessitating folinic acid treatment directly.
B: In megaloblastic anaemia secondary to Vitamin $B_{12}$ Megaloblastic anaemia due to Vitamin B12 deficiency specifically requires Vitamin B12 administration, making folinic acid inappropriate for this condition's core cause.
D: In treatment of folic acid deficiency This choice misrepresents folinic acid's role, as it primarily acts as a rescue agent in specific scenarios rather than treating general folic acid deficiencies.
A 54-year-old obese patient with type 2 diabetes and a history of alcoholism probably should not receive metformin because it can increase his risk of
Rationale:
Lactic acidosis. Metformin can lead to lactic acidosis, particularly in patients with compromised renal function, which is a risk for those with obesity, diabetes, and a history of alcoholism, making it contraindicated.
A: A disulfiram-like reaction. This reaction is associated with alcohol consumption and certain medications, but metformin does not elicit this effect, making it an unrelated concern for the patient.
B: Excessive weight gain. Metformin typically aids in weight management rather than causing weight gain, thus it is not a valid reason for avoiding this medication in the patient's situation.
C: Hypoglycemia. While metformin does lower blood sugar levels, it generally does not cause hypoglycemia on its own, especially when not used with other insulin-releasing medications, making this concern unfounded.
Progesterone administration
Rationale:
C: Sensitizes the uterus to oxytocin. Progesterone administration enhances the responsiveness of the uterus to oxytocin, thereby facilitating uterine contractions necessary for labor and delivery, which is crucial for reproductive functions.
A: Suppresses onset of menstruation. While progesterone plays a role in menstrual cycle regulation, its primary function is not to prevent menstruation but to prepare the endometrium for potential pregnancy.
B: Induces watery cervical secretion. Progesterone tends to thicken cervical mucus rather than induce watery secretions, as it aims to create a barrier that protects the uterus from pathogens during pregnancy.
D: Cornifies vaginal epithelium. Progesterone primarily maintains the vaginal epithelium's secretory properties rather than promoting keratinization; estrogen is more involved in the cornification process of the vaginal lining.
The gut controls the entry of ingested iron in the body of
Rationale:
C: Complexing excess iron to form ferritin which remains stored in the mucosal cell and is shed off. The gut effectively manages iron absorption by converting excess iron into ferritin, ensuring that surplus levels are safely stored within the mucosal cells and released as necessary, thus maintaining homeostasis and preventing toxicity from free iron in the body.
A: Regulating the availability of apoferritin which acts as the carrier of iron across the mucosal cell. This option focuses solely on carrier availability, neglecting the critical role of ferritin in iron storage and regulation.
B: Regulating the turnover of apoferritin-ferritin interconversion in the mucosal cell. While relevant, this option emphasizes interconversion processes rather than the direct mechanism of excess iron complexation and storage as ferritin.
D: Regulating the number of transferring receptors on the mucosal cell. This choice addresses iron transport and uptake, but does not encompass the essential function of ferritin in excess iron handling and storage.
The purpose/purposes served by the progestin component of the combined estrogen + progestin contraceptive pill is/are
Rationale:
D: The progestin component in combined contraceptive pills serves multiple purposes: it suppresses ovulation, induces a withdrawal bleed at the end of the cycle, and reduces the risk of endometrial cancer, making it essential for effective contraception and overall reproductive health.
A: Suppression of ovulation This option only addresses one function of progestin, neglecting its role in inducing withdrawal bleeding and cancer risk reduction.
B: Prompt bleeding at the end of the course While inducing a withdrawal bleed is a function, it overlooks the critical roles of ovulation suppression and endometrial cancer risk mitigation.
C: Blockade of increased risk of endometrial carcinoma This choice focuses solely on cancer risk reduction, ignoring the suppression of ovulation and the induction of withdrawal bleeding that progestin also provides.
Which of the following changes in the patient's blood cell concentration most likely occurred as a result of her therapy?
Rationale:
Decreased lymphocytes. This change typically occurs in patients undergoing certain therapies, particularly those affecting the immune system, leading to a reduction in lymphocyte levels due to their targeted suppression or destruction.
A: Decreased neutrophils Neutrophils are often increased in response to inflammation or infection, and their decrease is less common in standard therapy contexts unless specific conditions apply.
B: Decreased erythrocytes Erythrocytes, or red blood cells, generally decrease in response to anemia or bone marrow suppression, which is not the primary impact of the therapy in question.
C: Increased basophils Basophils are typically not significantly affected by most therapies; their increase is usually associated with allergic reactions or specific hematological conditions rather than standard treatment responses.
Which of the following drugs did the patient most likely take?
Rationale:
Leuprolide. This drug is a GnRH agonist commonly used in the treatment of hormone-sensitive conditions, making it a likely candidate for the patient’s treatment regimen, especially if related to prostate cancer or endometriosis.
A: Degarelix. This medication is a GnRH antagonist, differing significantly in mechanism and application compared to leuprolide, which is not suitable for the same patient circumstances.
C: Cabergoline. Primarily utilized for conditions like hyperprolactinemia, this drug does not align with the treatment needs that leuprolide addresses, indicating a distinct therapeutic focus.
D: Pegvisomant. Designed for acromegaly management, pegvisomant acts on growth hormone receptors, thereby lacking the hormonal regulatory effects characteristic of leuprolide's applications in other conditions.
Therapeutically vitamin B1 has been employed most successfully in the treatment of
Rationale:
Vitamin B1 has been employed most successfully in the treatment of Beriberi.
Vitamin B1, or thiamine, is essential for carbohydrate metabolism and nerve function. Its deficiency leads to Beriberi, characterized by neurological and cardiovascular symptoms. Supplementation effectively alleviates these issues, highlighting its therapeutic significance in treating this condition.
A: Microcytic anemia. This condition primarily arises from iron deficiency or other nutritional deficiencies, not specifically linked to vitamin B1, making thiamine ineffective for its management.
B: Pellagra. Pellagra is caused by a deficiency of niacin (vitamin B3), not thiamine. Therefore, vitamin B1 does not address the underlying issues associated with this condition.
C: Scurvy. Scurvy results from a lack of vitamin C, leading to symptoms like gum disease and fatigue, which vitamin B1 does not remedy, rendering it unsuitable for treatment.
A 63-year-old female presents to clinic for a diabetes follow-up. She has been taking metformin for 3 years now, but her blood sugars have not been well controlled over the past year. Her average morning fasting blood sugar is 165mg\dL, and her 2-h postprandial is 205mg\dL. Glimepiride is added to her regimen. What is the mechanism of action of glimepiride?
Rationale:
Glimepiride increases insulin release from the pancreas. This mechanism is crucial for improving blood sugar control in patients with type 2 diabetes, particularly when other medications, like metformin, are insufficient.
A: Decreased glucagon release does not accurately describe glimepiride's action, as it primarily stimulates insulin secretion rather than directly influencing glucagon levels in the body.
C: Increased insulin sensitivity in peripheral tissues is more characteristic of medications like thiazolidinediones, while glimepiride's primary role is to enhance insulin secretion from pancreatic beta cells.
D: Inhibits hepatic gluconeogenesis refers to the action of metformin, not glimepiride, which focuses on increasing insulin levels rather than directly affecting glucose production in the liver.
Five patients with elevated cholesterol present to the ambulatory care clinic for treatment of abnormalities of cholesterol. Which of the following patients would best benefit from treatment with an HMG-CoA reductase inhibitor?
Rationale:
D: Total cholesterol = 220mg/dL, HDL = 100mg/dL. This patient exhibits elevated total cholesterol levels, which indicates a potential risk for cardiovascular diseases, making them an ideal candidate for HMG-CoA reductase inhibitor therapy to lower cholesterol effectively.
A: Total cholesterol = 180mg/dL, HDL = 100mg/dL. With a total cholesterol level within the normal range, this patient does not present significant hypercholesterolemia that necessitates treatment with statins.
B: Total cholesterol = 180mg/dL, LDL = 100mg/dL. The total cholesterol and LDL values are both normal, indicating no immediate need for intervention with HMG-CoA reductase inhibitors in this case.
C: Total cholesterol = 180mg/dL, HDL = 60mg/dL. Although this patient's HDL is reasonable, the total cholesterol remains normal, suggesting no requirement for HMG-CoA reductase inhibitors at this time.
A 27-year-old woman with amenorrhea, infertility, and galactorrhea was treated with a drug that successful restored ovulation and menstruation. Before being given the drug, the woman was carefully questioned about previous mental health problems, which she did not have. She was advised to take the drug orally. The drug used to treat this patient was probably.
Rationale:
Bromocriptine. This medication is effective in treating conditions like hyperprolactinemia, which can cause amenorrhea, infertility, and galactorrhea. By lowering prolactin levels, it successfully restores ovulation and menstruation in patients like her.
B: Desmopressin. This drug primarily treats diabetes insipidus and certain bleeding disorders, not menstrual irregularities or infertility. It does not address elevated prolactin levels associated with the woman's symptoms.
C: Human gonadotropin hormone. While this hormone can stimulate ovulation, it is typically used in cases of ovarian dysfunction rather than directly addressing hyperprolactinemia, which is likely the underlying issue here.
D: Leuprolide. This medication is a GnRH analog used to suppress gonadotropin release, often for conditions like endometriosis or prostate cancer, and is not suitable for treating prolactin-related issues.
The side effect which primarily limits acceptability of oral iron therapy is
Rationale:
Epigastric pain and bowel upset are the primary side effects that limit the acceptability of oral iron therapy. These gastrointestinal disturbances often lead to patient discomfort, causing many to discontinue treatment despite the necessity of iron supplementation for conditions like anemia.
B: Black stools create concern for patients but are a common, harmless result of iron intake, typically not leading to therapy discontinuation as significantly as gastrointestinal discomfort does.
C: Staining of teeth may occur with liquid iron formulations but does not affect the overall acceptability of oral iron therapy as much as gastrointestinal side effects do.
D: Metallic taste can be unpleasant but is generally tolerable for patients and does not significantly impact their willingness to continue oral iron supplementation compared to epigastric pain.
Which of the following would be an appropriate change in the treatment plan for a patient with osteoporosis and hypertension experiencing a significant decrease in bone mass despite current therapy?
Rationale:
C: Adding calcitonin to the current regimen would provide additional support for bone mass in a patient with osteoporosis, as it helps to inhibit bone resorption and promote bone density.
A: Substituting hydrochlorothiazide with propranolol does not address bone mass concerns and may exacerbate hypertension, as propranolol primarily targets heart rate and blood pressure management without directly influencing bone health.
B: Substituting raloxifene with ethinyl estradiol is inappropriate since ethinyl estradiol does not have the same protective effects on bone density as raloxifene, a selective estrogen receptor modulator.
D: Increasing the daily dose of calcium carbonate alone may not effectively address the significant decrease in bone mass, as calcium supplementation requires adequate vitamin D levels for optimal absorption and utilization in bone health.
All of the following conditions are causes of hyperthyroidism except
Rationale:
Hyperthyroidism can be caused by several conditions, but Hashimoto's thyroiditis typically leads to hypothyroidism rather than hyperthyroidism. This autoimmune disorder primarily results in thyroid gland damage and reduced hormone production.
A: Graves' disease This autoimmune disorder is a leading cause of hyperthyroidism, characterized by overproduction of thyroid hormones due to stimulation of the thyroid gland.
C: Toxic multinodular goiter This condition arises from multiple nodules producing excess thyroid hormones, leading to hyperthyroidism through increased hormonal output from the thyroid gland.
D: Triiodothyronine toxicosis This condition involves elevated levels of triiodothyronine, a thyroid hormone, and directly contributes to hyperthyroidism, resulting from excessive hormone production.
Glucose entry into the cells of the following organ/tissue is highly dependent on the presence of insulin.
Rationale:
Glucose entry into the cells of adipose tissue is highly dependent on the presence of insulin. Insulin facilitates the uptake of glucose by stimulating glucose transporter proteins in adipose cells, allowing efficient energy storage and metabolic regulation.
A: Brain Glucose enters brain cells through specific transporters that operate independently of insulin, ensuring a constant energy supply regardless of insulin levels for critical brain functions.
B: Liver While insulin influences glucose metabolism in the liver, it does not solely dictate glucose entry, as hepatocytes can uptake glucose via other pathways, including the action of glucagon.
D: Kidney tubules Glucose reabsorption in kidney tubules primarily occurs through sodium-glucose transporters, which do not rely on insulin, ensuring glucose is conserved and preventing its loss in urine.
The following may help alleviate symptoms associated with prostatic hyperplasia EXCEPT:
Rationale:
Clonidine may help alleviate symptoms associated with prostatic hyperplasia EXCEPT. Clonidine primarily acts as an antihypertensive agent and does not directly target the urinary symptoms related to prostatic hyperplasia, making it less effective in this context compared to other options that specifically address urinary flow and prostate enlargement.
B: Tamsulosin specifically targets alpha-1 adrenergic receptors in the prostate, effectively relaxing muscles and improving urinary flow in patients with prostatic hyperplasia.
C: Doxazosin, an alpha-1 blocker, reduces urinary symptoms by relaxing smooth muscles in the prostate and bladder neck, enhancing urine flow and relieving obstruction.
D: Finasteride is a 5-alpha-reductase inhibitor that reduces prostate size and alleviates symptoms by blocking the conversion of testosterone to dihydrotestosterone, addressing the root cause of prostatic hyperplasia.
Which of the following actions was most likely to contribute to the therapeutic effect of prednisone in the patient's Crohn disease?
Rationale:
Increased catabolism of prostaglandins. This action likely reduces inflammation and immune response in Crohn's disease, leading to improved symptoms and therapeutic outcomes associated with prednisone treatment.
B: Decreased number of circulating neutrophils. While neutrophils play a role in inflammation, their reduction does not directly address the underlying mechanisms of Crohn’s disease as effectively as prostaglandin catabolism.
C: Increased proliferation of T cells. Boosting T cell numbers would potentially exacerbate inflammatory responses in Crohn’s disease, counteracting the intended therapeutic effects of prednisone.
D: Increased activation of complement system. Enhancing complement activity typically contributes to inflammation, which contradicts the purpose of prednisone as an anti-inflammatory medication in managing Crohn's disease.
Which of the following was most likely the primary goal for restarting prednisone treatment in this patient?
Rationale:
Restarting prednisone treatment aimed to avoid opportunistic infections after surgery. This medication is crucial for immunosuppressed patients, as it helps maintain adequate immune function, reducing the risk of infections during recovery.
A: To avoid adrenal insufficiency after surgery. While adrenal insufficiency is a concern, the primary focus here is on preventing infections, not solely managing adrenal function postoperatively.
B: To speed up surgical wound healing. Prednisone can have adverse effects on healing; hence, its use is not primarily aimed at enhancing the recovery of surgical wounds.
D: To promote gallbladder relaxation before surgery. Gallbladder relaxation does not relate to the main objective of managing immune response postoperatively, making this option irrelevant in this context.
In isolated fibroblast or epithelial cells, retinoids enhance the synthesis of following protein
Rationale:
Retinoids enhance the synthesis of fibronectin in isolated fibroblast or epithelial cells. This protein plays a crucial role in cell adhesion, migration, and tissue repair, making it vital for cellular functions impacted by retinoids.
B: Collagenase promotes the degradation of collagen rather than its synthesis, which does not align with the enhancing effects of retinoids on protein production in these cells.
C: Certain species of keratin are important for structural integrity, but retinoids primarily boost the synthesis of fibronectin instead, rather than keratin, in this context.
D: All of the above suggests that retinoids enhance the synthesis of multiple proteins, but evidence specifically supports an increase in fibronectin production rather than the others listed.
Hormones that are useful in the diagnosis of endocrine insufficiency include
Rationale:
All of the above. Hormones such as corticotropin-releasing hormone, cosyntropin, and gonadotropin-releasing hormone are pivotal in diagnosing endocrine insufficiency, as they help assess various hormonal axes and gland functions in the body.
A: Corticotropin-releasing hormone This hormone initiates the release of adrenocorticotropic hormone, but by itself does not provide a comprehensive assessment of all endocrine insufficiencies.
B: Cosyntropin This synthetic analog of adrenocorticotropic hormone is useful for adrenal function testing but does not encompass the full range of endocrine diagnoses.
C: Gonadotropin-releasing hormone While essential for reproductive function, it alone does not evaluate the broader spectrum of endocrine insufficiencies affecting other hormone systems.
What is the antidote for Warfarin?
Rationale:
Vitamin K. This vitamin acts as the primary antidote for Warfarin, reversing its anticoagulant effects by aiding in the synthesis of clotting factors dependent on vitamin K, thus restoring normal blood coagulation.
A: Vitamin D. This vitamin plays a crucial role in calcium metabolism and bone health, but it does not have any effect on Warfarin's anticoagulation properties.
B: Vitamin C. While this vitamin is vital for immune function and collagen synthesis, it does not influence the coagulation process affected by Warfarin.
D: Vitamin B. This group of vitamins is essential for energy metabolism and neurological function, yet it lacks any role in counteracting Warfarin's blood-thinning effects.
A diagram of the menstrual cycle in a 19-year-old woman who complains of dysmenorrhea is shown as follows. Which of the following points represents the highest level of estradiol?
Rationale:
C. The highest level of estradiol in the menstrual cycle is represented by point C, typically occurring just before ovulation when the developing follicle releases increasing amounts of this hormone.
A: Letter A. This point indicates the early follicular phase, where estradiol levels are relatively low as the ovarian follicles begin to mature.
B: Letter B. This point reflects the mid-follicular phase, where estradiol rises but has not yet reached its peak close to ovulation.
D: Letter D. This point represents the luteal phase, where estradiol levels begin to decline after ovulation, leading to lower hormone concentrations.
A 45-year-old woman with diabetes and hypertension presents to the primary care clinic with a cough. The nonproductive cough started about 2 weeks ago. She has not had a fever, congestion, or been around any sick contacts. However, she was recently started on lisinopril. The physician decides to switch her to losartan, and the patient reports that her cough has ceased. What is the mechanism of action of losartan?
Rationale:
Losartan inhibits angiotensin II receptor. This action blocks the effects of angiotensin II, leading to vasodilation and reduced blood pressure, which can alleviate symptoms such as cough linked to other medications like lisinopril.
A: Activates angiotensin I receptor. This option misrepresents losartan's function; it does not activate any receptors but rather inhibits the angiotensin II receptor specifically.
B: Activates angiotensin II receptor. This choice incorrectly suggests losartan promotes angiotensin II receptor activity, which contradicts its role as an antagonist that inhibits receptor activation.
C: Inhibits angiotensin-converting enzyme. This response pertains to a different class of medications, namely ACE inhibitors, and does not align with losartan's specific mechanism as an angiotensin II receptor blocker.
Hypercoagulability and dermal vascular necrosis due to protein C deficiency is known to be an early-appearing adverse effect of treatment with
Rationale:
Hypercoagulability and dermal vascular necrosis due to protein C deficiency is known to be an early-appearing adverse effect of treatment with Warfarin.
Warfarin inhibits vitamin K-dependent clotting factors, leading to a temporary procoagulant state, particularly in patients with protein C deficiency. This imbalance can result in thrombosis and skin necrosis shortly after initiating therapy, highlighting the need for careful monitoring and management in susceptible individuals.
A: Aspirin inhibits platelet aggregation, primarily affecting arterial thrombus formation, and does not typically induce hypercoagulability or vascular necrosis as a direct effect in treatment scenarios.
B: Clopidogrel functions similarly to aspirin by preventing platelet activation; it does not cause the specific coagulation abnormalities associated with protein C deficiency or initiate dermal vascular issues.
C: Heparin acts as an anticoagulant by enhancing antithrombin III, thus preventing clot formation; it does not lead to hypercoagulability or skin necrosis related to protein C levels.
A 78-year-old postmenopausal woman has been steadily losing weight over the past 6 months. She has no family history of breast or endometrial cancer. Which steroid hormone could she be given to increase her appetite?
Rationale:
D: Megestrol is an appetite stimulant commonly prescribed for individuals experiencing weight loss, especially in postmenopausal women. Its progestin properties help enhance appetite and promote weight gain, making it suitable for this patient.
A: Drospirenone primarily acts as a contraceptive and does not significantly influence appetite or weight gain, rendering it unsuitable for addressing the woman's weight loss issues.
B: Ethinyl estradiol is mainly used for hormonal contraception and does not typically serve as an appetite stimulant, thus failing to address the woman's nutritional needs effectively.
C: Medroxyprogesterone can influence appetite but is primarily used for menstrual irregularities and does not have the same efficacy as megestrol for stimulating appetite in this context.
Carbimazole acts by inhibiting
Rationale:
Carbimazole acts by inhibiting the oxidation of iodide. This inhibition prevents the conversion of iodide into its active form, thereby disrupting the synthesis of thyroid hormones, which is crucial for regulating metabolism.
A: Iodide trapping disrupts the uptake of iodide into the thyroid gland, but carbimazole specifically targets the oxidation process, not the initial trapping mechanism.
C: Proteolysis of thyroglobulin involves the breakdown of stored thyroid hormone, yet carbimazole's primary action focuses on iodide oxidation rather than altering thyroglobulin metabolism directly.
D: Synthesis of thyroglobulin protein refers to the creation of the precursor for thyroid hormones, but carbimazole does not prevent its formation; it specifically inhibits iodide oxidation in hormone synthesis.
A 56-year-old woman with diabetes who takes metformin is scheduled to undergo a CT scan of the abdomen and pelvis with IV contrast. Her last dose of metformin was this morning. She presents to the imaging center ready for the test. When she tells the technician that she takes metformin, her CT scan is cancelled despite her serum creatinine being 1mg\dL. What is the reason for cancellation of the test?
Rationale:
Metformin use in patients undergoing contrast-enhanced imaging raises concerns about lactic acidosis, particularly when renal function may be compromised. Although her serum creatinine is normal, the risk remains significant, prompting cancellation for safety.
A: Allergic reaction potential The technician's decision does not stem from concerns about allergies, as metformin does not typically induce allergic reactions related to IV contrast usage in this scenario.
C: Nephrotoxic effects of the contrast The primary concern is not the nephrotoxic effects of the contrast itself, especially since her serum creatinine level of 1 mg/dL indicates stable renal function.
D: Neurotoxic effects of the contrast Neurotoxicity is not a recognized issue with the specific contrast used for CT scans, making this option irrelevant in the context of the patient's metformin use.